Feng Chi Biotech (ROCO:6744) Other Current Receivables: NT$5.7 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6744 Feng Chi Biotech Corp ROCO:6744
82 GF Score
Price NT$13.55
GF Value NT$20.80
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Feng Chi Biotech Other Current Receivables?

Feng Chi Biotech ROCO:6744 -11.15% 82 Other Current Receivables is NT$5.7 Mil as of Dec. 2025. GuruFocus rates ROCO:6744 with a GF Score™ of 82/100 and a GF Value™ of NT$20.80 (Possible Value Trap). The stock has 5 warning signs investors should review.

Feng Chi Biotech's Other Current Receivables for the quarter that ended in Dec. 2025 was NT$5.7 Mil.

Feng Chi Biotech's quarterly Other Current Receivables increased from Dec. 2024 (NT$0.33 Mil) to Jun. 2025 (NT$5.88 Mil) but then stayed the same from Jun. 2025 (NT$5.88 Mil) to Dec. 2025 (NT$5.71 Mil).

Feng Chi Biotech's annual Other Current Receivables increased from Dec. 2023 (NT$0.26 Mil) to Dec. 2024 (NT$0.33 Mil) and increased from Dec. 2024 (NT$0.33 Mil) to Dec. 2025 (NT$5.71 Mil).

Feng Chi Biotech Other Current Receivables Related Terms

Feng Chi Biotech Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Feng Chi Biotech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Feng Chi Biotech Other Current Receivables Chart

Feng Chi Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.46 0.73 0.26 0.33 5.71

Feng Chi Biotech Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.19 0.33 5.88 5.71
ROCO:6744
82GF Score
Feng Chi Biotech Corp ROCO:6744
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Feng Chi Biotech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of NT$5.7 Mil mean?
Feng Chi Biotech (ROCO:6744) has a Other Current Receivables of NT$5.7 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Feng Chi Biotech and its competitors.
Is Feng Chi Biotech's Other Current Receivables too high?
Feng Chi Biotech's current Other Current Receivables is NT$5.7 Mil. Overall, Feng Chi Biotech has a GF Score™ of 82/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Feng Chi Biotech's Other Current Receivables compare to VRTX and REGN?
Feng Chi Biotech's Other Current Receivables of NT$5.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Feng Chi Biotech and its competitors. Feng Chi Biotech's current Other Current Receivables is NT$5.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Feng Chi Biotech stock overvalued right now?
Based on GuruFocus' analysis, Feng Chi Biotech (ROCO:6744) is currently considered Possible Value Trap. The stock's GF Value™ is NT$20.80, compared to a current price of NT$13.55 — trading 34.9% below its estimated fair value. The current Other Current Receivables is NT$5.7 Mil. Feng Chi Biotech's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Feng Chi Biotech (ROCO:6744), the current Other Current Receivables is NT$5.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Feng Chi Biotech (ROCO:6744) Overvalued in 2026?

Based on GuruFocus' analysis, Feng Chi Biotech stock appears to be undervalued. The current stock price of NT$13.55 is trading 34.9% below its estimated GF Value™ of NT$20.80. GuruFocus considers Feng Chi Biotech to be Possible Value Trap.

Key valuation signals for ROCO:6744:

  • Other Current Receivables: NT$5.7 Mil
  • GF Value™: NT$20.80 vs. price of NT$13.55 (34.9% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the ROCO:6744 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Feng Chi Biotech Business Description

Address No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.
82GF Score

Get the complete analysis for ROCO:6744

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.55
Price
NT$20.80
GF Value